Regentatlantic Capital LLC Organon & Co. Transaction History

Regentatlantic Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$31.66 - $38.9 $5,413 - $6,651	-171 Reduced 2.05%	8,156 $275,000
Q1 2022 May 02, 2022	SELL	$30.45 - $39.36 $30,206 - $39,045	-992 Reduced 10.64%	8,327 $291,000
Q4 2021 Jan 27, 2022	SELL	$28.67 - $37.13 $7,224 - $9,356	-252 Reduced 2.63%	9,319 $284,000
Q3 2021 Nov 15, 2021	SELL	$28.63 - $35.64 $47,010 - $58,520	-1,642 Reduced 14.64%	9,571 $314,000
Q2 2021 Aug 12, 2021	BUY	$28.45 - $38.0 $319,009 - $426,094	11,213 New	11,213 $339,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Regentatlantic Capital LLC with notifications on news.